RxDoctor Payments Data

Sarah Boxley, MD

Psychiatry · Scottsboro, ALNPI 1740452176

Payments from drug & device makers

$792in general payments, 2019–2025

Across 75 payments — averaging $10.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$212
  • AbbVie$160
  • Johnson & Johnson$107
  • Axsome Therapeutics, Inc.$94
  • Alkermes, Inc.$77
  • Supernus Pharmaceuticals, Inc.$42
  • plus $99 from 6 others

What the payments were for

  • Food & beverage$792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$792 in reported general payments places this provider in the 50th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$20,300
Medicare patients
76
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate261$849,387
Abilify MaintenaAripiprazole57$163,619
Invega TrinzaPaliperidone Palmitate14$151,964
IngrezzaValbenazine Tosylate17$145,684
Abilify AsimtufiiAripiprazole25$133,435
VraylarCariprazine Hcl68$100,500
Risperdal ConstaRisperidone Microspheres38$71,745
UzedyRisperidone17$49,863
Risperidone ErRisperidone Microspheres23$48,443
RexultiBrexpiprazole27$43,504
AuvelityDextromethorphan Hbr/Bupropion48$33,111
Aripiprazole201$11,472
Paliperidone ErPaliperidone52$11,121
BelsomraSuvorexant23$10,264
Asenapine Maleate36$8,580

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$107$1,073,096313 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii, Rexulti$14$340,558109 claims
AbbVieVraylar$160$100,50068 claims
Teva Pharmaceuticals USA, Inc.Uzedy$13$49,86317 claims
Axsome Therapeutics, Inc.Auvelity$94$33,11148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Scottsboro

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →